Bridging the Gap from Access to Impact

Session details:

Despite significant investments in pharmaceutical-sponsored patient access and affordability programs, awareness and utilization among eligible patients remain critically low. Without deliberate activation—defined as the strategic promotion, integration, and scaling of these programs—their impact is limited, and return on investment is constrained.

This panel discussion will explore practical steps to increasing your brand’s “Activation Quotient” starting today, extending your programs’ reach, increasing enrollment and utilization, and ultimately improving patient outcomes. Pharma brand, access, and patient support experts will discuss real-world case studies and highlight how leveraging technology and strategic partnerships dramatically enhances the visibility and utilization of access and affordability initiatives. Attendees will gain a clear roadmap to maximizing the reach and ROI of patient support initiatives while driving measurable improvements in patient outcomes.

This expert panel hosted by GoodRx will feature a range of perspectives on activating your access and affordability programs, including strategies to:

• Understand the necessity of proactive activation for patient affordability programs to effectively increase patient participation
  Leverage external partners to more efficiently reach, identify, and screen eligible patients—at scale
  Measure and demonstrate successful integration of medication affordability programs within pharma+partner ecosystems
  Overcome some common barriers to activation, including lack of data standardization, low patient engagement, and inconsistent technology integration